Flexion Therapeutics - ZILRETTA® for Osteoarthritis

Returning guest, Dr. Mike Clayman, co-founder and CEO of Flexion Therapeutics discusses their FDA approved drug ZILRETTA® ((triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis and how the company navigated the pandemic to keep meds in the hands of treating physicians and patients. He talks about how physicians are using ZILRETTA in place of elective surgeries, hence, the major increase in unit purchases from April to June 2020. #ZILRETTA #FlexionTherapeutics #Osteoarthritis Visit our website www.healtprofessionalradio.com.au Follow us on our social media channels Facebook:   / hprfm   Twitter:   / healthproradio   Google+: https://plus.google.com/+HealthProfes... Pinterest:   / healthprora.  . Linkedin:   / heal.  . Instagram:   / healthprofe.  . Subscribe to our podcast channels Soundcloud:   / healthprofessi.  . Itunes: https://itunes.apple.com/nz/podcast/h... Support us on Patreon   / hpr